Related Experiment Video
Updated: Feb 5, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of
Susan Schenk1, Quenten Highgate
1School of Psychology, Victoria University of Wellington, Wellington, New Zealand.
Abstract:
Most studies on discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) have been conducted using a relatively low dose (1.5 mg/kg), and those studies have invariably implicated serotonergic mechanisms. In contrast, dopaminergic mechanisms mediate the discriminative stimulus effects of amphetamine (AMPH). Some studies have suggested that the discriminative stimulus effects of a higher (3.0 mg/kg) dose of MDMA might rely on both serotonergic and dopaminergic mechanisms. This study aimed to determine effects of selective dopamine (DA) and serotonin (5HT) antagonists on the discriminative stimulus properties of AMPH (0.5 mg/kg) and MDMA (3.0 mg/kg). Separate groups of rats were trained to discriminate AMPH (0.5 mg/kg) or MDMA (3.0 mg/kg) from saline using a food-reinforced drug-discrimination procedure. Effects of DA (SCH 23390: 0.003-0.03 mg/kg and eticlopride: 0.03-0.3 mg/kg) or 5HT (ritanserin: 1.0-10.0 mg/kg, WAY-100635: 0.3-1.0 mg/kg and GR129375: 1.0-3.0 mg/kg) antagonists on the discriminative stimulus effects of both drugs were determined. Both DA antagonists dose-dependently decreased the AMPH but not the MDMA discrimination. None of the 5HT antagonists altered the discriminative stimulus effects of either drug. The MDMA (3.0 mg/kg) stimulus comprises both a DAergic and 5HTergic response, and the results suggest that either one is sufficient, but not required, to maintain the stimulus effects.
Insights
Higher doses of MDMA (3,4-methylenedioxymethamphetamine) involve both dopamine and serotonin systems. Dopamine antagonists blocked amphetamine discrimination but not MDMA, suggesting flexible mechanisms for MDMA
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) are typically studied at low doses (1.5 mg/kg), implicating serotonergic mechanisms.
- Dopaminergic mechanisms are known to mediate the effects of amphetamine (AMPH).
- Higher doses of MDMA (3.0 mg/kg) may involve both dopaminergic and serotonergic pathways.
Purpose of the Study:
- To investigate the role of selective dopamine (DA) and serotonin (5HT) antagonists in the discriminative stimulus effects of amphetamine (AMPH) and MDMA.
- To determine if dopaminergic or serotonergic systems are necessary for the discriminative stimulus properties of AMPH and a higher dose of MDMA.
Main Methods:
- Rats were trained to discriminate between AMPH (0.5 mg/kg) or MDMA (3.0 mg/kg) and saline using a food-reinforced drug-discrimination procedure.
- The effects of selective DA antagonists (SCH 23390, eticlopride) and 5HT antagonists (ritanserin, WAY-100635, GR129375) on drug discrimination were assessed.
- Antagonists were administered at specific dose ranges to evaluate their impact on stimulus generalization.
Main Results:
- Both DA antagonists dose-dependently reduced AMPH discrimination but did not affect MDMA discrimination.
- None of the tested 5HT antagonists altered the discriminative stimulus effects of either AMPH or MDMA.
- The discriminative stimulus of MDMA (3.0 mg/kg) appears to involve both DAergic and 5HTergic components.
Conclusions:
- Dopaminergic mechanisms are critical for the discriminative effects of AMPH.
- The discriminative stimulus of a high dose of MDMA can be maintained by either dopaminergic or serotonergic pathways, as neither is strictly required.
- This suggests a degree of flexibility in the neurobiological substrates mediating the subjective effects of MDMA at higher doses.
More Related Videos
10:50Behavioral Determination of Stimulus Pair Discrimination of Auditory Acoustic and Electrical Stimuli Using a Classical Conditioning and Heart-rate Approach
Published on: June 6, 2012
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Stereotypes, Prejudice, and Discrimination
Hypothesis: Accept or Fail to Reject?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...